XORTX Therapeutics (XRTX) Assets (2020 - 2026)
XORTX Therapeutics' (XRTX) quarterly Assets came in at $2.1 million in Q1 2026, down 38.7% YoY from $3.5 million in Q1 2025, and down 20.08% on a QoQ basis from $2.7 million in Q4 2025.
XORTX Therapeutics (XRTX) Assets (2020 - 2026) Analysis & Trends
XORTX Therapeutics (XRTX) has 7 years of Assets data on file, last reported at $2.1 million in Q1 2026.
- Quarterly Assets fell 38.7% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 38.7% YoY) and the FY2025 annual result came in at $2.7 million, down 34.46% from the prior year.
- Assets fell to $2.1 million in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Assets ranged from a high of $14.6 million in Q1 2022 to a low of $2.1 million in Q1 2026.
- A 5-year average of $6.7 million and a median of $5.4 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets soared 84.35% — and 2025, when it tumbled 42.87%.
- Tracing XRTX's Assets over 5 years: stood at $12.3 million in 2022, then plunged by 46.2% to $6.6 million in 2023, then tumbled by 38.34% to $4.1 million in 2024, then slumped by 34.46% to $2.7 million in 2025, then slipped by 20.08% to $2.1 million in 2026.
- The last three Assets figures came in at $2.1 million (Q1 2026), $2.7 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 19.82 Bn |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - | 2.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.14 Mn |
| Dec 31, 2025 | 2.68 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 3.50 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Sep 30, 2024 | 3.85 Mn |
| Jun 30, 2024 | 4.80 Mn |
| Mar 31, 2024 | 6.05 Mn |
| Sep 30, 2023 | 6.64 Mn |
| Jun 30, 2023 | 7.80 Mn |
| Mar 31, 2023 | 9.66 Mn |
| Dec 31, 2022 | 12.34 Mn |
| Sep 30, 2022 | 11.47 Mn |
| Jun 30, 2022 | 12.59 Mn |
| Mar 31, 2022 | 14.56 Mn |
| Dec 31, 2021 | 17.48 Mn |
| Sep 30, 2021 | 6.22 Mn |
| Dec 31, 2020 | 1.76 Mn |